Review article: Gastro-oesophageal reflux disease - Pathophysiological issues of clinical relevance

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 16, Issue 4, 2002, Pages 65-71

  Penagini, R ^a   Carmagnola, S ^a   Cantu, P ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACID;

CLINICAL FEATURE; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; HYPERSENSITIVITY; LOWER ESOPHAGUS SPHINCTER; MOTOR DYSFUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE RELAXATION; STIMULATION; STOMACH; ESOPHAGUS FUNCTION DISORDER; HELICOBACTER INFECTION;

ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMAN; HUMANS;

EID: 0036268542     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Costs of acid-related disorders to a health maintenance organization
2. An evidence-based appraisal of reflux disease management. The Genval Workshop report
3. Heartburn - The acid test
4. Ambulatory 24-hour pH-metry in the diagnosis of gastrocesophageal reflux disease
5. Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies
6. Speed of healing and symptoms relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
7. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis
8. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux
9. Ambulatory esophageal pH recording in gastroesophageal reflux: Relevance to the development of esophagitis
10. Esophageal peristaltic dysfunction in peptic esophagitis
11. Endoscopy-negative acid reflux disease
12. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux
13. Motor event underlying gastroesophageal reflux in ambulant patients with reflux oesophagitis
14. Transient lower esophageal sphincter relaxation
15. The time pattern of gastroesophageal reflux
16. Characteristics and frequency of transient relaxations of the lower sphincter in patients with reflux esophagitis
17. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease
18. Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease
19. Gastric emptying: A contributory factor in gastro-oesophageal reflux activity?
20. Analysis of spontaneous gastroesophageal reflux and esophageal acid clearance in patients with reflux esophagitis
21. Effect of esophageal emptying and saliva on clearance of acid from the esophagus
22. Effect of peristaltic dysfunction on esophageal Volume clearance
23. Mechanism of gastroesophageal reflux in ambulant health human subjects
24. Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease
25. The effect of hiatus hernia on gastro-oesophageal junction pressure
26. Prevalence of hiatal hernia and its influence on gastro-oesophageal reflux
27. Relationship between endoscopic hiatus hernia and gastroesophageal reflux symptoms
28. Determinants of gastroesophageal junction incompetence: Hiatal hernia, lower esophageal sphincter, or both?
29. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanism other than transient LES relaxations
30. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distension in reflux patients with hiatal hernia
31. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia
32. Impairment of esophageal emptying with hiatal hernia
33. Evaluation of esophageal tests in the diagnosis of reflux esophagitis
34. Dilated intercellular spaces: A morphological feature of acid reflux-damaged human esophageal epithelium
35. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans
36. The relationship between stress and symptoms of gastroesophageal reflux: The influence of psychological factors
37. Relaxation training reduces symptoms reports and acid exposure in patients with gastroesophageal reflux disease
38. Acid gastroesophageal reflux and symptom occurence. Analysis of some factors influencing their association
39. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics
40. Fat and esophageal sensitivity to acid
41. Duodenal fat intensifies the perception of heartburn
42. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: Evidence for a spectrum of visceral sensitivity in GORD
43. Hearturn without oesophagitis: Efficacy of omeprazole therapy and features determining therapeutic response
44. Esophageal acid sensitivity in Barrett's esophagus
45. Mucosal sensitivity and salivary response to infused acid in patients with columnar-lined oesophagus
46. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus
47. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone
48. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease
49. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disese
50. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls
51. Multivariate analysis of phatophysiological factors in reflux oesophagitis
52. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus
53. The significance of cagA+ Helicobacter pylori in reflux oesophagitis
54. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion
55. Helicobacter pylori infection and chronic gastric acid hyposecretion
56. Barrett's esophagus
57. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
58. Opposing time trends of peptic ulcer and reflux disease
59. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: A randomised controlled trial
60. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: A randomized controlled trial
61. Bile reflux and oesophagitis
62. Composition of gastro-oesophageal refluxate
63. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease
64. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity
65. Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease?
66. Declined human esophageal mucin secretion in patients with severe reflux esophagitis
67. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease
68. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subject
69. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation
70. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans
71. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis
72. Control of transient lower esophageal sphincter relaxations and reflux by the GABA agonist baclofen in normal subjects
73. Visceral hypersensitivity: Facts, speculations and challenges